Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2 | P00734 | 4/20 | 0.62 |
| ▸ | CALCR | P30988 | 4/20 | 0.58 |
| ▸ | CRHR1 | P34998 | 1/20 | 0.54 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.54 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.52 |
| ▸ | AGTR2 | P50052 | 1/20 | 0.52 |
| ▸ | NTSR2 | O95665 | 1/20 | 0.50 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.50 |
| ▸ | ANPEP | P15144 | 1/20 | 0.50 |
| ▸ | LNPEP | Q9UIQ6 | 1/20 | 0.50 |
| ▸ | APLNR | P35414 | 1/20 | 0.50 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.49 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.49 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.49 |
| ▸ | NMBR | P28336 | 1/20 | 0.49 |
| ▸ | GRPR | P30550 | 1/20 | 0.49 |
| ▸ | NMUR2 | Q9GZQ4 | 1/20 | 0.48 |
| ▸ | NMUR1 | Q9HB89 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29793680 | 0.98 | F2 (0.64) | F2CALCRCRHR1CRHR2AGTR1 | |
| SCHEMBL29510563 | 0.90 | NTSR2 (0.58) | AGTR1AGTR2NTSR2NTSR1 | |
| SCHEMBL29467322 | 0.90 | OPRD1 (0.56) | NTSR2NTSR1OPRM1OPRD1OPRK1 | |
| SCHEMBL30176423 | 0.86 | CALCR (0.68) | F2CALCRCRHR1CRHR2 | |
| SCHEMBL30504147 | 0.86 | F2 (0.67) | F2CALCRCRHR1CRHR2NTSR2 | |
| SCHEMBL30504145 | 0.86 | F2 (0.67) | F2CALCRCRHR1CRHR2NTSR2 | |
| SCHEMBL30504153 | 0.86 | F2 (0.67) | F2CALCRCRHR1CRHR2NTSR2 | |
| SCHEMBL30586509 | 0.84 | F2 (0.60) | F2CALCRCRHR1CRHR2NTSR2 | |
| SCHEMBL30504289 | 0.84 | CALCR (0.61) | F2CALCRCRHR1CRHR2AGTR1 | |
| SCHEMBL31583875 | 0.83 | NMUR2 (0.54) | F2NMUR2NMUR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115919996-A | Adiponectin peptidomimetics for the treatment of ophthalmic diseases | 雅利斯塔制药公司 | 2023-04-07 | — | — | CN | claimed |
| US-20230074446-A1 | ADIPONECTIN PEPTIDOMIMETICS FOR TREATING OCULAR DISORDERS | ALLYSTA PHARMACEUTICALS INC (US) | 2023-03-09 | — | — | US | claimed |
| US-20220331393-A1 | ADIPONECTIN PEPTIDOMIMETICS FOR TREATING OCULAR DISORDERS | ALLYSTA PHARMACEUTICALS INC (US) | 2022-10-20 | — | — | US | claimed |
| US-11464825-B2 | Adiponectin peptidomimetics for treating ocular disorders | ALLYSTA PHARMACEUTICALS, INC. (US) | 2022-10-11 | — | — | US | claimed |
| CN-107530396-B | Adiponectin peptidomimetics for the treatment of ophthalmic diseases | 雅利斯塔制药公司 | 2022-08-26 | — | — | CN | claimed |
| US-11273197-B2 | Adiponectin peptidomimetics for treating ocular disorders | ALLYSTA PHARMACEUTICALS, INC. (US) | 2022-03-15 | — | — | US | claimed |
| CN-109689678-B | Agonist peptides for adiponectin receptors | B·B·金 | 2024-04-09 | — | — | CN | disclosed |
| CN-116535469-A | Peptides having adiponectin receptor agonist function and agonists of adiponectin receptor | B·B·金 | 2023-08-04 | — | — | CN | disclosed |
| CN-115919996-A | Adiponectin peptidomimetics for the treatment of ophthalmic diseases | 雅利斯塔制药公司 | 2023-04-07 | — | — | CN | disclosed |
| US-20230074446-A1 | ADIPONECTIN PEPTIDOMIMETICS FOR TREATING OCULAR DISORDERS | ALLYSTA PHARMACEUTICALS INC (US) | 2023-03-09 | — | — | US | disclosed |
| US-20220331393-A1 | ADIPONECTIN PEPTIDOMIMETICS FOR TREATING OCULAR DISORDERS | ALLYSTA PHARMACEUTICALS INC (US) | 2022-10-20 | — | — | US | disclosed |
| US-11464825-B2 | Adiponectin peptidomimetics for treating ocular disorders | ALLYSTA PHARMACEUTICALS, INC. (US) | 2022-10-11 | — | — | US | disclosed |
| CN-107530396-B | Adiponectin peptidomimetics for the treatment of ophthalmic diseases | 雅利斯塔制药公司 | 2022-08-26 | — | — | CN | disclosed |
| EP-4014985-A1 | ADIPONECTIN PEPTIDOMIMETICS FOR TREATING OCULAR DISORDERS | Allysta Pharmaceuticals, Inc. (US) | 2022-06-22 | — | — | EP | disclosed |
| US-11273197-B2 | Adiponectin peptidomimetics for treating ocular disorders | ALLYSTA PHARMACEUTICALS, INC. (US) | 2022-03-15 | — | — | US | disclosed |